---
document_datetime: 2025-08-27 14:04:12
document_pages: 3
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/lixiana-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: lixiana-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 1.6966214
conversion_datetime: 2025-12-27 09:05:34.416672
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Lixiana

Procedural steps taken and scientific information after the authorisation*

*Due to the Agency`s update of its procedure management systems, an additional document, reflecting the historical lifecycle may be available in the 'Assessment history' section. For the complete product lifecycle procedures, you may need to also refer to EPAR - Procedural steps taken and scientific information after authorisation (archive) .

| Application number   | Scope                                   | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary                                        |
|----------------------|-----------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|------------------------------------------------|
| Variation type IB /  | This was an application for a variation | 24/07/2025                          |                                             | SmPC and PL                      | To update section 5.2 of the SmPC to correct 3 |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| EMA/VR/0000272457                     | following a worksharing procedure according to Article 20 of Commission Regulation (EC) No 1234/2008. C.I HUMAN AND VETERINARY MEDICINAL PRODUCTS - C.I.z Other variation - Accepted To update section 5.2 of the SmPC to correct 3 numbers in the sub-section `Paediatric population'. In addition, the Applicant took the opportunity to update the annexes to the latest QRD version and to make minor corrections throughout the annexes. The MAH also update the list of local representatives in the Package Leaflet for Lixiana for Czechia.   |            |     | numbers in the sub-section `Paediatric population'. In addition, the Applicant took the opportunity to update the annexes to the latest QRD version and to make minor corrections throughout the annexes. The MAH also update the list of local representatives in the Package Leaflet for Lixiana for Czechia.   |
|---------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Variation type IA / EMA/VR/0000275040 | A. ADMINISTRATIVE CHANGES - A.7 Deletion of manufacturing sites for an active substance, intermediate or finished product, packaging site, manufacturer responsible for batch release, site where batch control takes place, or supplier of a starting material, reagent or excipient (when mentioned in the dossier)* - Accepted                                                                                                                                                                                                                     | 12/06/2025 | N/A |                                                                                                                                                                                                                                                                                                                   |
| Variation type IB / EMA/VR/0000265363 | This was an application for a variation following a worksharing procedure according to Article 20 of Commission Regulation (EC) No 1234/2008. B.I.d.1.a Re-test period/storage period -                                                                                                                                                                                                                                                                                                                                                               | 12/06/2025 | N/A |                                                                                                                                                                                                                                                                                                                   |

<div style=\"page-break-after: always\"></div>

|                                       | B.I.d.1.a.4 Extension or introduction of a re- test period/storage period supported by real time data - Accepted                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |            |     |
|---------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|
| Variation type IA / EMA/VR/0000248718 | B.II.b.3 Change in the manufacturing process of the finished product, including an intermediate used in the manufacture of the finished product - B.II.b.3.a Minor change in the manufacturing process - Accepted B.II.e.1.a Qualitative and quantitative composition - B.II.e.1.a.1. Solid pharmaceutical forms - Accepted B.II.e.4 Change in shape or dimensions of the container or closure (immediate packaging) - B.II.e.4.a Non-sterile medicinal products - Accepted B.II.e.4 Change in shape or dimensions of the container or closure (immediate packaging) - B.II.e.4.a Non-sterile medicinal products - Accepted | 12/02/2025 | N/A |